Mark Robbins

2.3k total citations
25 papers, 1.0k citations indexed

About

Mark Robbins is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Robbins has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Robbins's work include Cardiac Valve Diseases and Treatments (7 papers), Coronary Interventions and Diagnostics (5 papers) and Acute Myocardial Infarction Research (5 papers). Mark Robbins is often cited by papers focused on Cardiac Valve Diseases and Treatments (7 papers), Coronary Interventions and Diagnostics (5 papers) and Acute Myocardial Infarction Research (5 papers). Mark Robbins collaborates with scholars based in United States, Switzerland and Canada. Mark Robbins's co-authors include Deepak L. Bhatt, Eric J. Topol, Derek P. Chew, Stephen G. Ellis, Michael S. Lauer, Jakob P. Schneider, Debabrata Mukherjee, Marco Roffi, Fredric J. Pashkow and James B. Young and has published in prestigious journals such as Circulation, The American Journal of Cardiology and Journal of Vascular Surgery.

In The Last Decade

Mark Robbins

25 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Robbins United States 14 709 460 224 132 125 25 1.0k
Alessandro Maloberti Italy 19 609 0.9× 177 0.4× 139 0.6× 127 1.0× 39 0.3× 121 1.1k
Janina Stępińska Poland 18 719 1.0× 260 0.6× 226 1.0× 112 0.8× 18 0.1× 111 1.0k
Laurie G. Futterman United States 10 510 0.7× 287 0.6× 85 0.4× 124 0.9× 31 0.2× 44 765
Ana Teresa Timóteo Portugal 19 831 1.2× 211 0.5× 153 0.7× 176 1.3× 23 0.2× 150 1.1k
Mahesh Bikkina United States 16 840 1.2× 240 0.5× 109 0.5× 160 1.2× 19 0.2× 73 1.1k
Venkata Alla United States 17 494 0.7× 336 0.7× 308 1.4× 120 0.9× 17 0.1× 92 944
Albert J. Kolibash United States 22 1.0k 1.4× 317 0.7× 150 0.7× 126 1.0× 50 0.4× 44 1.3k
Casper N. Bang Denmark 19 712 1.0× 170 0.4× 133 0.6× 89 0.7× 20 0.2× 63 1.0k
Basil S. Lewis Israel 15 863 1.2× 228 0.5× 130 0.6× 63 0.5× 21 0.2× 42 1.1k
Gregg J. Reis United States 11 908 1.3× 404 0.9× 52 0.2× 233 1.8× 66 0.5× 14 1.3k

Countries citing papers authored by Mark Robbins

Since Specialization
Citations

This map shows the geographic impact of Mark Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Robbins more than expected).

Fields of papers citing papers by Mark Robbins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Robbins. The network helps show where Mark Robbins may publish in the future.

Co-authorship network of co-authors of Mark Robbins

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Robbins. A scholar is included among the top collaborators of Mark Robbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Robbins. Mark Robbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mieghem, Nicolas M. Van, Michael J. Reardon, Steven J. Yakubov, et al.. (2020). Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial. EuroIntervention. 16(10). 833–841. 23 indexed citations
2.
Fudim, Marat, et al.. (2014). Percutaneous Management of RetroFlex 3 Balloon Rupture and Separation of the Edwards Sapien Delivery System. Texas Heart Institute Journal. 41(6). 641–644. 7 indexed citations
3.
Lynch, Donald, et al.. (2013). Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation. Journal of Thrombosis and Thrombolysis. 35(4). 476–482. 17 indexed citations
4.
Fudim, Marat, Roshanak Markley, & Mark Robbins. (2013). Transcatheter aortic valve replacement for aortic bioprosthetic valve failure with cardiogenic shock.. PubMed. 25(11). 625–6. 11 indexed citations
5.
6.
Fudim, Marat, Keith Green, Joseph L. Fredi, Mark Robbins, & David Zhao. (2012). Peripheral Vascular Complications During Transcatheter Aortic Valve Replacement: Management and Potential Role of Chronic Steroid Use. Perspectives in Vascular Surgery. 24(4). 206–209. 7 indexed citations
7.
Ryan, Catherine L., et al.. (2010). Altered social interaction in adult rats following neonatal treatment with domoic acid. Physiology & Behavior. 102(3-4). 291–295. 18 indexed citations
8.
Roffi, Marco, Michael Brändle, Mark Robbins, & Debabrata Mukherjee. (2009). Current perspectives on coronary revascularization in the diabetic patient.. PubMed. 59(2). 124–36. 7 indexed citations
9.
Salles-Cunha, Sérgio X., et al.. (2004). Ultrasound findings after radiofrequency ablation of the great saphenous vein: Descriptive analysis. Journal of Vascular Surgery. 40(6). 1166–1173. 24 indexed citations
10.
Robbins, Mark & Eric J. Topol. (2002). Inflammation in acute coronary syndromes.. Cleveland Clinic Journal of Medicine. 69(Suppl_2). SII130–SII130. 10 indexed citations
11.
Roffi, Marco, Debabrata Mukherjee, Derek P. Chew, et al.. (2002). Lack of Benefit From Intravenous Platelet Glycoprotein IIb/IIIa Receptor Inhibition as Adjunctive Treatment for Percutaneous Interventions of Aortocoronary Bypass Grafts. Circulation. 106(24). 3063–3067. 132 indexed citations
12.
Mukherjee, Debabrata, Deepak L. Bhatt, Mark Robbins, et al.. (2001). Renal artery end-diastolic velocity and renal artery resistance index as predictors of outcome after renal stenting. The American Journal of Cardiology. 88(9). 1064–1066. 16 indexed citations
13.
Chew, Derek P., Deepak L. Bhatt, Mark Robbins, et al.. (2001). Effect of Clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. The American Journal of Cardiology. 88(6). 672–674. 115 indexed citations
14.
Mukherjee, Debabrata, Derek P. Chew, Mark Robbins, et al.. (2001). Clinical Application of Procedural Platelet Monitoring during Percutaneous Coronary Intervention among Patients at Increased Bleeding Risk. Journal of Thrombosis and Thrombolysis. 11(2). 151–154. 2 indexed citations
15.
Novaro, Gian M., Mark Robbins, Michael S. Firstenberg, et al.. (2000). Disk Embolization of a Björk-Shiley Convexo-Concave Mitral Valve: A Cause of Sudden Cardiovascular Collapse and Mesenteric Ischemia. Journal of the American Society of Echocardiography. 13(5). 417–420. 1 indexed citations
16.
Robbins, Mark, Gary S. Francis, Fredric J. Pashkow, et al.. (1999). Ventilatory and Heart Rate Responses to Exercise. Circulation. 100(24). 2411–2417. 181 indexed citations
17.
18.
Robbins, Mark, et al.. (1992). The progestin-only oral contraceptive —its place in postpartum contraception. Advances in Contraception. 8(2). 93–103. 6 indexed citations
19.
Farr, Gaston, et al.. (1991). A comparative clinical trial of the TCu 380A, lippes loop D and multiload Cu 375 IUDs in Indonesia. Contraception. 44(2). 141–154. 36 indexed citations
20.
Janowitz, Barbara, et al.. (1990). Postpartum Sterilization by Nurse-Midwives in Thailand. International Family Planning Perspectives. 16(2). 55–55. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandro Maloberti Breakdown of academic impact, for papers by Janina Stępińska Breakdown of academic impact, for papers by Laurie G. Futterman Breakdown of academic impact, for papers by Ana Teresa Timóteo Breakdown of academic impact, for papers by Mahesh Bikkina Breakdown of academic impact, for papers by Venkata Alla Breakdown of academic impact, for papers by Albert J. Kolibash Breakdown of academic impact, for papers by Casper N. Bang Breakdown of academic impact, for papers by Basil S. Lewis Breakdown of academic impact, for papers by Gregg J. Reis
Rankless by CCL
2026